viously described (49) . In about half, the exogenous creatinine clearance was used as a measure of glomerular filtration rate (GFR); in the remainder, the inulin clearance was employed.
To obtain low urinary pH, pretreatment was with NH&l or HCl, and an intravenous infusion of NaCl (. I 50 M) in 5 % mannitol was used to elevate the urine flow rate. To achieve alkaline urine, the infusion consisted of 0.3 M NaHC03.
The rate of infusion was constant during the clearance periods. The compound under study was given as a priming dose and also added to the infusion. For each part of an experiment, three consecutive I o-min clearance periods were taken. At the midpoint of each an arterial blood sample was obtained and the urinary pH determined. The reported values are the means of three periods. The range of values seldom exceeded =t IO % of the mean and never ~20%. A detailed protocol illustrating the general procedure is given in Table I .
Factors influencing renal excretion of foreign organic acids. Am. J. Physiol. 207 (5) : 953-963.
I g64.-Renal excretory mechanisms for 16 organic acids (mostly benzoates) were examined by standard renal clearances in the dog to establish their participation in an active secretory system, and to ascertain the factors influencing their simultaneous tubular reabsorption. Active secretion was demonstrated by clearances greater than the glomerular filtration rate and by inhibition of excretion by presumably competitively transported acids, i.e., hippurates. Critical chemical substituents essential for transport could not be identified. For reabsorption by non-ionic diffusion, the relative roles of acidic strength, lipid solubility, and urinary pH are evaluated with emphasis on the variation in the importance of each of these factors. kidney urine inorganic electrolytes drug excretion urinary pH secretion active transport reabsorption drug metabolism S OME ORGANIC ACIDS, actively secreted by the renal tubule, undergo subsequent reabsorption (47, 49, 50 ). This may be of sufficient magnitude to completely mask the secretory process under ordinary physiological conditions. Because of this, we have examined the excretory patterns of a variety of acidic compounds, mainly substituted benzoic acids, some not previously considered to participate in secretory transport. Although it was not feasible to study each compound in great detail, certain differences in excretory behavior were readily detected, and these differences are consistent with current concepts of the mechanism of excretion of organic electrolytes (35).
METHODS
All experiments were conducted in trained, unanesthetized, female, mongrel dogs using procedures pre- vents were washed successively with I N NaOH, I N HCl and several times with water before use. In addition to routine cleaning, the glassware was rinsed with I N HCl and alcohol before final water rinses. For all analyses a reagent blank was determined for each run. In addition, in each experiment before the administration of the test substance, urine and plasma for "blank" determinations were obtained in a control clearance period. These values were subtracted from the experimental determinations. Recoveries from urine were always as good as or better than from plasma, and only the latter are given below.
Phenoxyacetic acid. TWO milliliters of sample or diluted sample, 0.5 ml of 6 N HCl, and 40 ml of chloroform containing I .5 % isoamyl alcohol were shaken mechanically for 15 min in a glass-stoppered centrifuge tube. After centrifugation and aspiration of the aqueous phase, 30 ml of the solvent layer was transferred to a fresh tube containing 5 ml of phosphate buffer, o. I M, pH 7. After 5 min of shaking and centrifugation, an aliquot of the buffer was transferred to a quartz cuvette and the optical density determined at 267 rnp. At concentrations of pg/ml, the recoveries from plasma ranged from go to 110%.
Plasma blanks averaged 7 pg/ml; urine blanks, 0.22 mg/min. o-Nitrobenzoic acid. Utilizing the same general procedure the sample size was 2 ml; acid, 0.25 ml of concentrated HCl; solvent, 30 ml of ethylene dichloride. Twenty milliliters of the solvent layer were then shaken with 5 ml of phosphate buffer, o. I M, pH 7, and optical density determined at 268 rnp. Recovery from plasma (5-50 fig/ml) ranged from g5 to g7 %; plasma blanks averaged 2 pg/ml; urinary blanks, 0.06 mg/min. A variation of this determination involved substituting 6 ml of o. I N NaOH for the phosphate buffer in the second extraction and subsequently treating 4 ml of the alkaline phase with I ml of 6 N HCl and subjecting the solution to polarographic analysis. The polarographic method is free of interference from probenecid which is extracted along with the nitrobenzoate, and it was therefore used in experiments with this inhibitor. m-Nitrobensoic acid. The method was the same as for o-nitrobenzoate except that the solvent was a I : I mixture of ethylene dichloride and carbon tetrachloride, 40 ml of solvent were used for the initial extraction, and wavelength was 267 rnp. The polarographic method was also applied for this compound. The recoveries from plasma (I 0-50 ,ug/ml) ranged from g6 to I 03 %. Plasma blanks averaged I pg/ml; urinary blanks, 0.02 mg/min. p-Nitrobensoic acid. The method was the same as for the meta isomer except that the wavelength used was 272 mp. The polarographic method was also applied. Recoveries from plasma (I 0-50 pg/ml) were from g6 to I I 4 %. Plasma blanks averaged I .5 hg/ml; urinary blanks, 0.0 I mg/min. m-Hydroxyberqoic acid. The method was similar to that for p-hydroxybenzoate (47) except that the acidifying agent was 0.5 ml of citrate buffer, 0.5 M, pH 2; and the optical density of the final color was determined at 480 mp. Recoveries from plasma (6-50 ,ug/ml) ranged from gr to I 04 %. Plasma blanks averaged 2 ,ug/ml; urinary blanks, 0.02 mg/min. Gentisic acid. Two milliliters of sample, 0.5 ml citrate buffer, 0.5 M, pH 2, and 40 ml of ether were shaken and then centrifuged.
Twenty milliliters of the ether phase was shaken with 5 ml ether-saturated phosphate buffer, 0.1 M, pH 7, and the optical density determined at 320 mp. Recoveries from plasma (25-100 pg/ml) ranged from g3 to 107 %. Plasma blanks averaged 2 pg/ml; urinary blanks, 0.05 mg/min.
3-Nitrosalicylic acid. The method was the same as for o-nitrobenzoic acid except that the final alkaline phase was o. I M NaOH, and the optical density was determined at 435 mp. The recoveries from plasma pg/ml) were 96-98 %. Plasma blanks averaged g-Nitrosalicylic acid. The method was the same as for o-nitrobenzoate except 0.5 ml of 6 N HCl was used for acidification and the optical density was determined at 278 mp. Recoveries from plasma (I 0-50 pg/ml) were 97-104 %. Plasma blanks averaged I pg/ml; urinary blanks, 0.05 mg/min. pNitrosaZicyZic acid. The method was the same as for 3-nitrosalicylate except that the optical density was determined at 450 mp. Recoveries from plasma (10-50 pg/ml) were go-92 %. Plasma blanks averaged I pg/ml; urinary blanks, 0.002 mg/min.
g-Hydroxy-a-phenylcinchoninic acid. This procedure was similar to that for phenoxyacetic acid except that acidification was accomplished-with 0.5 ml of 2 N HCl. The final aqueous phase was 4 ml of 0.1 N NaOH and the optical density was determined at 254.5 mh. Recoveries from plasma (12-50 pg/ml) ranged from g6 to 103 %. Plasma blanks averaged 2 pg/ml; urinary blanks, 0.04 mg/min. p(Di-n-propyl) sulfamyl-z-nitrobensoic acid. One milliliter of sample plus g ml of I N HCl were shaken with 15 ml ethylene dichloride.
After centrifugation, IO ml of the solvent layer were shaken with 5 ml of phosphate buffer, o. I M, pH 7, and the optical density of the aqueous layer determined at 236 mp. Recoveries from plasma (25-1 oo pg/ml) ranged from g8 to 102 %. Plasma blanks averaged 5 pg/ml; urinary blanks, 0.08 mg/min.
Ben&ziaside.
The procedure was similar to that for gentisate except that the acidifying agent was 0.5 ml of 6 N HCl, the final aqueous phase was o. I N NaOH, and the optical density determined at 297 rnp. Recoveries from plasma (25-100 pg/ml) ranged from g7 to 102 7%. Plasma blanks averaged 4 ,ug/ml; urinary blanks, 0.07 mg/min.
Evidence for the specificity of the methods taken from the literature is stated in the original papers. Phenoxyacetic acid is not metabolized (5 I ) and o-nitrobenzoate is metabolized to only a small extent (38); consequently it is reasonable to assume that the products measured are the same as the original compounds.
For all other compounds the urinary components determined were compared to the administered compounds by the method of Brodie and Udenfriend (I 0). In all cases, the results with apparent and authentic compounds agreed within the limits of the method. It was concluded that under the conditions of these experiments the substances measured were the same as the compounds administered. Most of the compounds used were reagent-grade commercial products. Carinamide was a gift from Merck Sharp and Dohme; phenylbutazone and sulfinpyrazine were donated by Geigy; and benzthiazide was provided by Pfizer.
The syntheses of 2-phenyl-g-hydroxycinchoninic acid (3 I ) and 4-nitrosalicylic acid ( I 3) have been described.
4-(di-n-propyl)-sulfamyl-2-nitrobenzoic acid was prepared as follows and has been given the abbreviated name of 2-nitroprobenecid. By means of Meerwein's (33) modification of the Sandmeyer reaction, 4-amino-2-nitrobenzoic acid was converted to 2-nitro-4-chlorosulfamylbenzoic acid. This, upon reaction with excess di-n-propylamine, formed the di-n-propylamine salt of di-n-propylsulfamyl-2-nitrobenzoic acid from which the parent acid was liberated.
Recrystallization experiments with known inhibitors of tubular secretion, the decreased clearance was associated with an absolute fall in excretory rate. This resulted in a variable rise in plasma level. In no experiment with inhibitors could the fall in clearance be attributed simply to an increasing plasma level and consequent self-depression of clearance. In the succeeding tables the results are arranged with the experiments during alkaline infusion presented first, in order of descending plasma concentrations of the compound studied, followed by the mannitol-NaCl experiments in a similar order. A few experiments were designed to give two steady-state phases, the first acidosis, the second alkalosis, e.g., experiment 25, aciduria, there was net reabsorption.
In two experiments with succinate and in one with 2,4-DNP there was a marked decrease in phenoxyacetic acid excretion, the clearance ratios going from net secretion to net reabsorption.
In three experiments, the administration of PAH produced similar results. Nitrobensoates. These substances were examined because of the acidic strength of the ortho isomer. The results are listed in Table 3 . The excretion of each compound was decreased by the administration of probenecid or PAH. The clearance of the strongest acid (ortho) app roximated the renal plasma flow, and was not significantly affected by changes in urinary pH. The meta isomer had a maximal clearance of about two-thirds the filtration rate, and this was higher in alkalosis than acidosis. After correction for protein binding (exp. 22) it is seen that the clearance exceeds the filtration rate with alkaline urine. In the other experiments with lower plasma levels, there was an increase in protein binding to an average of approximately 85 %. The resulting levels in the ultrafiltrate were too low for accurate estimation and are not reported. The para isomer shows net secretion, and its excretory rate is also pH dependent.
Hydroxybensoates. Table  4 gives the results obtained with the meta and para isomers of salicylate and with gentisate (2,5-dihydroxybenzoate) .
With the meta compound, net tubular secretion could not be demonstrated even after correction for plasma protein binding. t Too low for accurate estimaperiments at hand to discriminate finely between the excretory patterns of the various compounds.
The protocol in Table I shows the general plan of the experiments.
After a suitable equilibration period during which the plasma level of phenoxyacetic acid became stabilized, the clearances indicated net tubular secretion. Following the administration of 2 ,4-dinitrophenol, excretion fell and the clearances indicated net reabsorption. In this experiment, as in many others, the rate of urine flow increased in the experimental periods. This is attributed to the continuous infusion of hypertonic solutions. By analogy to other compounds, an increase in urine flow would result in an increased clearance (4g,50). Thus the changes in fluid balance inherent in the experimental procedure may tend to minimize the effects of the inhibitors.
In Table I may be decreased in an acid urine to less than the amount filtered, the relative effects of urinary pH are less striking than for the ortho isomer, salicylate (49). In the case of gentisate, there is little effect of urine pH. Net reabsorption was not demonstrated, but it is possible that this might occur at lower urine flows.
Nitrosalicylates. These compounds were examined because it has been reported that the intestinal epithelium is poorly permeable to the 5-nitro isomer at physiological pH (40). As seen in Table 5 , all three compounds are secreted, and their excretory rates are depressed by PAH. Their excretions are somewhat pH dependent, but this is much less marked than in the case of salicylate. As will be discussed later, this behavior is consistent with the fact that these are considerably stronger acids than is salicylate. Experiment 60 illustrates the possi .bility th .at pH dependence may not necessarilv be due to tubular reabsorption as demonstrated for other organic acids. In this instance, the increased clearance with an alkalin .e urine was associated with an increase in the free unbound fraction in plasma, i.e., rise in F/P ratio. However, the 957 significance of this factor has not yet been explored systematically.
Hydroxyphenylcinchoninic acid (HPC). This compound depresses phenol red transport, but its own excretion was reported to be very low in the normal dog (I 4, 32). As a consequence, this was considered to be a "refractory substrate," analogous to that originally proposed for probenecid (4). As summarized in Table 6 , the excretion of HPC is markedly increased in an alkaline urine and is depressed by the administration of PAH. Since protein binding is so extensive, the clearance ratios are consistent with tubular secretion. Carinamide. The variable clearance ratios previously reported for this compound suggested an uncertain degree of tubular secretion (6). Table 6 shows unequivocal tubular secretion in an alkaline urine and net tubular reabsorption when the urine is acid. 2-Nitroprobenecid.
This was synthesized to obtain an analogue of probenecid with a much lower pKa. As in the case of probenecid (50), this is secreted by a PAHsensitive mechanism (Table  6 ). However, unlike probenecid, its excretion is only slightly sensitive to urinary pH change (Fig. I) .
Phenylbutazone and suZjinpyrazone. The pH dependence of phenylbutazone excretion shown in Table 6 t Too low for accurate estimapendent mechanism. These serve to fill in the continuum from salicylate on the one hand, which they resemble chemically, to p-aminohippurate, on the other, whose behavior they mimic in the kidney. The over-all behavior of these compounds is summarized in Table 7 . Criteria for active secretion. With many compounds it is not possible to attribute the net secretion of an organic acid to non-ionic diffusion (35, 49 From the viewpoint of reactive substituents, phenoxyacetic acid is distinguished by their paucity. This emphasizes the difficulty in visualizing a "lock-and-key" interaction with the secretory system. Are these acids secreted by the hippurate system? The major affirmative evidence on this point is the observation that PAH or hippurate inhibits the excretion of these acids. This is further supported by the inhibition experiments with probenecid, 2 ,4-dinitrophenol, and succinate, which have similar effects on the secretion of PAH. As stated above, it has been suggested that those acids whose excretion is pH dependent are themselves secreted by a mechanism differing from that involved in hippurate excretion.
However, the present evidence argues against this. The excretion of some hippurates is influenced by urinary pH (29) and there are some benzoates in the present series whose excretion is not particularly pH sensitive (see Table  7 for summary). In addition, the site of secretion for both types of acids is the same (18, 24, 49 active secretion of all compounds will be quantitatively the same. In enzymatic reactions, affinities and maximal rates may be different with each substrate for a given enzyme, and it is likely that this would hold for the corresponding kinetic equivalents of active transport systems.
Second, protein binding varies over a great range. Insofar as this limits the concentration of free compound it may influence the extent of secretion. Whether this becomes manifest in terms of clearance depends on the nature of the interaction of the compound with the secretory mechanism relative to the extent of its binding to plasma protein.
Thus chlorothiazide (5) and flumethiazide (37) are efficiently secreted in spite of extensive plasma protein binding, in contrast to phenol red whose secretion is partly limited by protein binding (36). The notion that chlorothiazide reacts strongly with the transport mechanism is supported by its relative resistance to inhibition (2).
On the other hand the relative weakness of the phenol red interaction is attested to by the shape of its tubular titration curve (41) . It should be emphasized that an increase in the nonprotein-bound fraction of a compound may result in less than a proportionate increase in secretion (36). However, others have incorrectly speculated that a a-fold variation in free compound might account for a more than 3o-fold change of clearance within a series of compounds (I 7). In the present study there is considerable variation in the protein binding of individual compounds from experiment to experiment. Part of this is attributable to differences in plasma level of the compound (20) .
Of probably greater significance are the variations in plasma-protein concentration which were undoubtedly produced by manipulations of the fluid balance. In addition, acid-base alterations may produce changes in protein binding, and in those instances in which there is a trend, it is in the expected direction, i.e., increased binding in acidosis (20) . By and large these variations do not obscure the effect of acid-base balance on excretion.
However, in the case of a-nitrosalicylate, the changes in clearance (UV/P) secondary to changes in acid-base balance are not accompanied by changes in corrected clearance (UV/F), and interpretation on the basis of changes in reabsorption is made somewhat uncertain.
Comparisons of clearances should be made at similar plasma concentrations.
Because of experimental and analytical necessities this is not always possible. However, it should be emphasized that the level at which the transport mechanism approaches saturation may vary from one compound to another. With certain compounds the ccusual" plasma level (based on experiments with PAH) may be excessive. This applies in the present experiments, especially to I;-nitroprobenecid where there is marked self-depression of clearance at low plasma levels (Fig. I) . Thus, the effect of physiological variables on clearance can be evaluated only when plasma concentrations are equivalent.
Fourth, a factor of special importance with these com- Thus it is possible that the excretion of some compounds was studied under conditions in which their tubular secretion was partially inhibited by their own metabolites.
With the more slowly excreted compounds, the rate of infusion considerably exceeded the rate of excretion while the plasma level remained constant.
This was especially marked with mhydroxybenzoate, for which the rate of excretion was one-fifth the rate of infusion. This suggests that there is a high rate of metabolism and that the low clearance rate can be in part its metabolites. Thus with the present heterogeneous group of compounds any a ttempt to correlate absolute clearance with properties determining passive reabsorption would be hazardous.
This does not preclude such studies in other instances (28, 29, 50) , particularly with series of compounds which have equally high maximal rates of excretion under conditions that inhibit reabsorption. @a as a determinant of secretion. Several investigators have noticed a rough correlation between the pKa and clearance of certain acids, the stronger acids being more rapidly excreted (I g, 2 I, 30). The role of the pKa in determining reabsorption is probably sufficient to explain this correlation (see below). However, Gutman et al. (2 I) are of the opinion that the pKa determines secretion as well. This is based on the observation that the differences in clearances between strong and weak acids in the phenylbutazone series was not abolished by alkalinizing the urine. This involves the implicit assumption that alkalinization of the urine completely prevents reabsorption. The fact that changes in urine flow influence clearance even with maximally alkaline urine is strong evidence that with certain compounds reabsorption occurs despite the alkalinity of the urine. The findings summarized in Table 7 make it abundantly clear that the pKa in the range studied is not a major determinant of secretion.
Tubular reabsoqhon. The marked influence of urinary pH on excretion of organic acids can best be explained on the basis of non-ionic diffusion (34). The reasons for considering the net direction of diffusion to be reabsorptive have been previously given (49). The magnitude of reabsorption by this mechanism will depend on the concentration gradient for the diffusing moiety and the permeability of the membrane to it. For the present, impermeability to anions is assumed. Permeability is determined largely by the ability of the undissociated acid to traverse the membrane and this is related to its lipid solubility.
With a given compound the chloroform-water partition coefficient (Table  7) presumably reflects this solubility, although the problem of choosing the proper model solvent persists (23). The concentration gradient, of course, will change along the length of the tubule and will in part be determined by the effect of fluid reabsorption, the addition of compound to luminal fluid by active transport, and the degree to which the compound is in the non-ionic state, which in turn is a function of its pKa and tubular fluid pH. Thus the following factors will contribute to high clearance of an acid: I) high rate of secretion; 2) high rate of urine flow; 3) low lipid solubility; 4) high urinary pH; 5) and a low pKa.
With the present compounds there is no evidence that secretory rates are equal, since under conditions designed to inhibit reabsorption (i.e., high urinary flow and pH) differences in clearance persist. It is not possible to exclude persistent reabsorption.
In most experiments, with either acid or alkaline urines, the flow rate was high. This tends to minimize reabsorption and may obscure the influence of other experimental variables. Nevertheless certain gross differences in behavior were detectable. The last column of low pKa values. Benzthiazide appears exceptional in that it is a weak acid and somewhat lipid soluble. It must be borne in mind, however, that net reabsorption is more difficult to demonstrate in the case of a highly bound substance, since this reduces the quantity of material filtered at the glomerulus (47). The next to the last column in Table 7 summarizes the influence of changes in urinary pH on the excretion of these acids. Of particular interest are the small effects on the excretions of benzthiazide which is the weakest acid in the series, and on 2-nitroprobenecid which is the strongest acid, but is a lipid soluble compound. Waddell and Butler (45) explained the failure of changes in urinary pH to influence the excretion of very weak acids (pKa > 7) on the basis that there is little resultant change in the relative proportion of the non-ionized moiety. Benzthiazide possibly falls into this category. Of greater relevance to the other compounds in this series are the observations of Gutman et al. (21) on phenylbutazone analogues, which are all stronger acids. They found that the excretion of the more acidic sulfinpyrazone was less pH dependent than the excretion of phenylbutazone.
With the stronger acids, the degree of ionization is relatively great at any pH of the urine. If, in a particular case, this were to result in a low rate of reabsorption by limiting the concentration of the non-ionic moiety in acid urine, it is obvious that further decreases in nonionic moiety consequent to alkalinization of the urine will not appreciably augment excretion. Further discussion of this point can best be made with reference to Fig. 2 At maximal urinary l pH, the excretion of these compounds is sensitive to changes in urinary flow rate indicating that reabsorption still occurs. Presumably, this reabsorption could be further reduced if it were possible to increase urine pH still more, and to do it throughout the length of the tubule. Thus reabsorption would eventually be reduced to insignificant levels and the clearance would reach a plateau. Curve A represents a compound similar to B in all respects except that it is a stronger acid, pKa being assumed to be two units lower. The solid line represents the situation expected if the pH changes were reflected along the length of the nephron. However, it is quite clear that the urinary acidity, pH < 6.5, necessary for extensive reabsorption of A can occur over a small portion of the nephron.
Consequently, the opportunity for reabsorption of A is diminished. Moreover, the medullary region of the distal nephron, where acidity can be greatest, is the region where blood flow is lowest. This might further limit the movement of material from urine to plasma. Consequently, the dotted line in Fig. 2 is a more probable description of the behavior of the stronger acid. The results with 2-nitroprobenecid (Table 6 and Fig. I ) are consistent with this interpretation.
This compound is a strong acid, but quite lipid soluble. Its excretion is not influenced by urinary pH changes in the region pH 8 to 7, and further decreases in pH have relatively little effect. The positions of cuwes A and B in Fig. 2 are determined by factors in addition to pKa. Thus, in the case of an acid with the pKa equal to that of B but IOO times less soluble in the lipid membrane than B, we would 1
